The page is the record's research on the issuer — no analyst, no rating, no view.

Enliven Therapeutics, Inc. (ELVN) — research page

US · us-cm-kg/NASDAQ/ELVN · as of 2026-11-08

Identity and listing

The issuer is Enliven Therapeutics, Inc., listed on NASDAQ under ticker ELVN, with ISIN US29337E1029. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States — Delaware. The segment is not on the record. The listing status is listed, not halted.

fieldvaluesource · read date
nameEnliven Therapeutics, Inc.source · 2026-11-08
exchangeNASDAQsource · 2026-11-08
tickerELVNsource · 2026-11-08
ISINUS29337E1029source · 2026-10-02
LEInot on the record
security typeCorporatesource · 2026-11-08
segmentnot on the record
sector2834 Pharmaceutical Preparationssource · 2026-11-08
jurisdictionUnited States — Delawaresource · 2026-11-08
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 133 filings in the twelve months to 2026-11-08, across 72 filing days. Of these, 55 are directors' dealings, 56 are regulatory filings, 11 are results, 4 are AGM/EGM filings, 3 are director changes, 2 are corporate news and 2 are prospectuses. The median gap between filing days is 3 days. The latest filing is a results filing dated 2026-11-05, 3 days before the record date. The median gap for NASDAQ issuers is 6.0 days, and the median latency is 5.0 days. The median gap for the sector is 6.0 days, and the median latency is 4.0 days. The issuer's 133 filings are above the NASDAQ median of 52 and above the sector median of 63.0.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer13333
exchange median: NASDAQ (4359 issuers)5265
sector median: 2834 Pharmaceutical Preparations (526 issuers)6364
datetypecategoryfiling
2026-11-05results10-Q10-Q — 10-Q
2026-11-05results8-K8-K — 8-K (items 2.02,9.01)
2026-11-03directors_dealings44
2026-10-27regulatory_filingSCHEDULE 13G/ASCHEDULE 13G/A
2026-10-21directors_dealings44

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover, as foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting, name change or segment move lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations page.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The earliest sealed date for the US market is 2021-01-04. The live record began on 2026-09-12.

Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
10.2
https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
10.3
https://data.sec.gov/submissions/CIK0001672619.json (identity.jurisdiction)
10.4
https://mcp.us-cm-kg.ai/events/NASDAQ/ELVN (the disclosure lines)
10.5
https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
10.6
https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://mcp.us-cm-kg.ai/record/NASDAQ/ELVN (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US29337E1029"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:2030b3c8a36e8eb0.